Virtual, online and hybrid medical meetings are here to stay.

Expect to see a virtual component even when in-person medical meetings resume. If you didn’t fall in love with virtual medical meetings in 2020, let’s just say you’re not alone. They came with their fair share of downsides, including the smaller volume of presented data and the lack of face-to-face [...]

A collaborative approach to greater diversity in clinical trials

The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades. Despite the introduction of US policies, beginning with the 1993 National Institutes of Health (NIH) Revitalization Act which called for the inclusion of more women and communities of colour in clinical [...]

Is COVID-19 improving pharma’s reputation?

A new Takeda study conducted by Ipsos MORI in the U.K. finds consumers and healthcare providers favor pharma companies with a clear sense of purpose. Thinking pharma might earn a reputation halo with its COVID-19 work? Not so fast, Takeda says. Its recent U.K. study finds only an incremental boost in positive consumer sentiment. [...]

Latin America: How pharma can navigate a complex market

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. There are a number of companies that, even in the last decade, have left the Latin American market completely because they just couldn’t [...]

Pharma Marketing: forget influencers, stick to patient connections

More community trust. Less forced connections. A recent UK survey found that only 14% percent of users mostly or completely trust lifestyle influencers, while 51% completely or mostly trust patient influencers. When it comes to branded pharma products, the survey was even more positive for patient influencers: 85% said they would be very or [...]

How COVID-19 is making pharma more resilient

How securing supply in a time of crisis will ensure future access, build resilience, and transform relationships. Since the start of the year, pharmaceutical companies have been riding a rollercoaster of challenges as the various strands came together to threaten supply chains. First, we saw a doubling or tripling of the usual demand for [...]

Pharma’s digital promos to doctors surging as priorities shift

Pharma companies rushed to get on physician and hospital screens this year with a big jump in professional ads tracked.During the pandemic, pharma advertising to consumers has surged with messages backing science, offering financial help with perscriptions and stressing the need to continue doctor visits and vaccinations.But behind-the-scenes spending—that is, advertising and promotions to physicians [...]

Pharma and healthcare digital advertising jumps during pandemic

The industry's increase of more than 14% puts it in the number two spot by growth rates, just behind computing products and consumer electronics at 18%. As advertising increasingly moves online, so has pharma and healthcare's share. This year the industry is expected to spend more than $9.5 billion on digital media, according to [...]

Kyowa Kirin illuminates rare disease with glowing digital makeup

The visually stunning effort illustrates the connection between phosphorus, an element known for its glowing properties, and XLH, which results from a lack of phosphorus in the body and causes abnormalities. Pharma Kyowa Kirin enlisted renowned makeup artist James Mac Inerney to apply digital glowing body paint on three people living with XLH. While [...]

Are rapid progress and patient engagement mutually exclusive?

COVID-19 has sparked a flurry of research and discoveries that are being made at an unprecedented rate – but patient engagement cannot and should not be left behind in the rush. SARS-CoV-2 has demonstrated both the strengths and the weaknesses of the life sciences ecosystem, and it is now up to the sector to [...]